Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alex azar
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
3
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
fda
medicaid
medicare
regeneron pharmaceuticals
trump administration
aducanumab
affordable care act
aldeyra therapeutics
alirocumab
alliance for aging research
alzheimer's disease
american patients first
What
drug
trump
administration
aducanumab
afternoon
alzheimer’s
amyloid
angry
angst
anti
anticipated
awaited
bagged
benefited
billions
bio
biogen
biogen’s
blueprint
brammer
cost
cut
despite
details
drugs
effects
failure
fear
felt
house
industry
long
losing
lost
lower
meant
nash
news
pharma
plan
Language
Current search:
national
×
" alex azar "
×
" raleigh-durham top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details